<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:protege="http://protege.stanford.edu/plugins/owl/protege#" xmlns:xsp="http://www.owl-ontologies.com/2005/08/07/xsp.owl#" xmlns:Thesaurus="http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Zebrafish Chemical Screening Reveals Impairment of <br /> Dopaminergic Neuronal <span id='am-4' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-5' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-6' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-7' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-8' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-9' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-10' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-11' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-12' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-13' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-14' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-15' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-16' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-17' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-18' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-19' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-20' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-21' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-22' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-23' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-24' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-25' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-26' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-27' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-28' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-29' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-30' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-31' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-32' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-33' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-34' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-35' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-36' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-37' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-38' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-39' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-40' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-41' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-42' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-43' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-44' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-45' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-46' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-47' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-48' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-49' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-50' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-51' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-52' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-53' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-54' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-55' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-56' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-57' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-58' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-59' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-60' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-61' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-62' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-63' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-64' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-65' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-66' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-67' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-68' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-69' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-70' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-71' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-72' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-73' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-74' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-75' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-76' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-77' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-78' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-79' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-80' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-81' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span>Survival</span> Cardiac Glycosides <br /> Yaping Sun1, Zhiqiang Dong1, Hadie Khodabakhsh1,2, Sandip Chatterjee1,3, Su Guo1* <br /> 1 Department Bioengineering Therapeutic Sciences, Programs Human Genetics Biological Sciences, University California San Francisco, San Francisco, <br /> California, United States America, 2 The George Washington University School Medicine, Washington, D.C., United States America, 3 The Scripps Research Institute, <br /> La Jolla, California, United States America <br />  <br />  <br />  <br />      <span id='am-1' about='protege:abstract' typeof='owl:Thing'>Abstract</span> <br />      Parkinson&#226;&#8364;&#8482;s disease neurodegenerative disorder characterized prominent degeneration dopaminergic (DA) <br />      neurons cell types. Here report chemical screen 5,000 compounds zebrafish, aimed at <br />      identifying small molecule modulators DA neuron development survival. We Neriifolin, member the <br />      cardiac glycoside family compounds, impairs survival differentiation zebrafish mammalian DA <br />      neurons. Cardiac glycosides inhibitors Na+/K+ ATPase activity widely used treating heart disorders. Our data <br />      suggest Neriifolin impairs DA neuronal survival targeting neuronal enriched Na+/K+ ATPase a3 subunit (ATP1A3). <br />      Modulation ionic homeostasis, knockdown p53, treatment antioxidants protects DA neurons Neriifolin- <br />      induced death. These results reveal previously unknown effect cardiac glycosides DA neuronal survival suggest <br />      mediated ATP1A3 inhibition, oxidative stress, p53. They elucidate potential approaches for <br />      counteracting neurotoxicity valuable class medications. <br />  <br />   Citation: Sun Y, Dong Z, Khodabakhsh H, Chatterjee S, Guo S (2012) Zebrafish Chemical Screening Reveals Impairment Dopaminergic Neuronal Survival by <br />   Cardiac Glycosides. PLoS ONE 7(4): e35645. doi:10.1371/journal.pone.0035645 <br />   Editor: Giorgio F. Gilestro, Imperial College London, United Kingdom <br />   Received November 22, 2011; Accepted March 19, 2012; Published April 26, 2012 <br />   Copyright: &#195;&#376; 2012 Sun et al. This open-access article distributed terms Creative Commons Attribution License, permits unrestricted <br />   use, distribution, reproduction medium, provided original author source credited. <br />   Funding: Funding provided NIH DA023904. The funder role study design, data collection analysis, decision publish, preparation the <br />   manuscript. <br />   Competing Interests: The authors declared competing interests exist. <br />   * E-mail: su.guo@ucsf.edu <br />  <br />  <br />  <br /> Introduction                                                                            ascending descending projections shortly hatching <br />                                                                                         [9,10]. While DA neurons conspicuously absent the <br />    Since discovery prominent chemical neurotransmitter                      ventral midbrain, ventral forebrain DA neurons ascending <span id='am-3' about='protege:TO' typeof='owl:Thing'>to</span> <br /> the vertebrate nervous system, dopamine (DA) recognized                           striatum (where ventral midbrain DA neurons mammals <br /> have important physiological functions including control                       project) likely functional counterpart mammalian <br /> of movement, cognition, affect, neuroendocrine                               midbrain DA neurons [11,12]. <br /> secretion [1,2]. Among various human disorders involving                               Zebrafish vertebrate model organism highly <br /> dysregulation DA systems, Parkinson&#226;&#8364;&#8482;s disease (PD) best-                     amenable chemical genetic studies [13,14]. Owing high <br /> characterized pathology DA neurons: degeneration                              fecundity small size embryos larvae fit <br /> substantia nigral DA neurons major cause                            96-well plates, zebrafish particularly suitable high <br /> common movement disorder (second common neurodegen- <br />                                                                                         content small molecule screening vivo. Such screens utilize <br /> erative disorder Alzheimer&#226;&#8364;&#8482;s disease). Recent studies show <br />                                                                                         transparency zebrafish embryos larvae monitor <br /> that neurodegeneration PD appears widespread only <br />                                                                                         perturbation distinct molecular markers cell types the <br /> affecting substantia nigral DA neurons, possibly underlies <br />                                                                                         context entire organism. Chemicals identified small <br /> some non-motor symptoms disease [3]. Since its <br />                                                                                         molecule screens important pharmacological tools probing <br /> introduction 50 years ago, L-DOPA, DA <br />                                                                                         underlying biological mechanisms disease models can <br /> replacement therapies, remain mainstream symptomatic <br />                                                                                         serve leads developing new therapeutics. Assays employing <br /> treatments PD, despite observations exert poor <br />                                                                                         wild-type, mutants, transgenic zebrafish embryos larvae <br /> control non-motor symptoms, moreover, their <br /> prolonged use leads debilitating effects [4]. Thus, better                    led discoveries small molecules regulate major <br /> understanding genetic environmental causes PD                        signaling pathways [15,16], cellular proliferation/differentiation <br /> will facilitate development new treatments neuropro-                        [17&#226;&#8364;&#8220;19], developmental toxicity [20,21], disease remodeling <br /> tective disease-modifying effects.                                                   [22,23], simple forms behavior [24,25]. <br />    DA neurons exhibit overall conserved organization function                          Despite functional significance DA neurons, small <br /> across vertebrates [5]. In developing zebrafish embryos, DA                             molecule screen modulators DA neuron development or <br /> neurons detected ventral forebrain (posterior tubercu-                       survival reported. In study, report vivo <br /> lum hypothalamus), dorsal forebrain (telencephalon), olfactory                      small molecule screen zebrafish goal identifying <br /> bulb retina [6,7] patterns closely resemble                     chemical regulators DA neuron development survival. We <br /> in adult zebrafish brain [8]. These neurons display adult-like                      uncover previously unknown neurotoxic effect cardiac <br />  <br />  <br />         PLoS ONE | www.plosone.org                                                  1                                  April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                         Chemical Genetics Dopaminergic Neurons <br />  <br />  <br /> glycosides DA neurons, identify approaches counteract               Neriifolin impairs survival specification or <br /> the neurotoxicity class medications.                               differentiation VFB DA neurons. <br />                                                                                  In addition affecting VFB DA neurons, noted dose- <br /> Results                                                                       dependent effect Neriifolin embryonic morphology. At high <br />                                                                               concentrations (10 mM higher), Neriifolin induced heart edema, <br /> Chemical screening identifies Neriifolin, disrupts                      dorsal curvature body axis, opaqueness brain that <br /> the <span id='am-238' about='xsp:pattern' typeof='owl:Thing'>pattern</span> DA neurons ventral forebrain                            suggestive overt neuro-degeneration. These observations <br />    In order identify small molecule regulators DA neuron                suggest cell organ types VFB DA neurons can <br /> development survival, established chemical screening                  affected drug. <br /> platform employing embryonic larval zebrafish. We treated <br /> dechorionated wild-type embryos 96-well plates (3 embryos              Na+/K+ ATPase a3 subunit (ATP1A3) likely target of <br /> well) chemicals 48 hours (<span id='am-2' about='protege:FROM' typeof='owl:Thing'>from</span> 24&#226;&#8364;&#8220;72 hours post                      Neriifolin DA neuronal death <br /> fertilization, hpf), final concentration 10 mM. At 72 hpf,               Cardiac glycosides inhibit activity Na+/K+ ATPases. In <br /> embryos fixed stained antibodies tyrosine               addition, affect growth factor receptor signaling, MAP <br /> hydroxylase (TH), rate-limiting enzyme dopamine synthesis              kinase, IP3, calcium, NF-kB signaling [26]. The beneficial <br /> and established marker DA NA neurons. The pattern                  effect cardiac glycosides heart function binding to <br /> of DA neurons visually analyzed compared                     inhibiting Na+/K+ ATPases, drive ATP-dependent <br /> vehicle control (1% DMSO) (Fig. 1A). The ventral forebrain                    active transport potassium (K+) ions cells sodium (Na+) <br /> (VFB) DA neurons focus analysis              ions cells. Na+/K+ ATPases oligomers composed at <br /> prominence similarity mammalian midbrain DA neurons                    polypeptides: a-subunit b-subunit. The a <br /> that degenerate PD.                                                        subunit catalytic subunit contains evolutionarily <br />    We screened libraries: Microsource library (containing             conserved cardiac glycoside-binding pocket. In mammals, a- <br /> 1520 FDA-approved compounds) Celera_IFLabs library                    subunit exists 4 isoforms (a1&#226;&#8364;&#8220;a4) distinct tissue-specific <br /> (containing 3500 compounds predicted target kinases),             expression. Among 4 isoforms, (atp1a1, 2, 3) are <br /> totaling 5020 compounds. 19 chemicals (0.3%) identified             expressed nervous a3 prominent <br /> altered pattern VFB DA neurons following treatment. After              [27]. In zebrafish, genes encoding subunit been <br /> further analyses, 17 compounds deemed general                  identified, exhibit distinctive expression patterns [28,29]. <br /> effect embryonic development turn affected VFB DA                     We atp1a3a gene prominently expressed in <br /> neurons pursued, leaving 2 compounds                     ventral brain region encompassed VFB DA neurons <br /> (0.03%) affected VFB DA neuronal patterns grossly                (Fig. 2A). To determine potential involvement atp1a3 DA <br /> affecting embryonic development. One compound                        neuronal survival, tested overexpression gene <br /> Celera library increased VFB DA neurons. However,                  rescue Neriifolin-induced DA neuronal death. Since <br /> unknown mechanism action, discussed                 zebrafish atp1a3a gene highly homologous human atp1a3 <br /> here. The compound named Neriifolin (Fig. 1B)                       [30], expressed human atp1a3 gene control the <br /> particularly interesting us: decreased VFB DA                 heat shock-inducible hsp70 promoter (Fig. 2B). This version the <br /> neurons, TH-positive NA neurons sympathetic ganglia               human atp1a3 gene carries mutations (Q108R N119D) in <br /> unaffected (Fig. 1C).                                                         cardiac glycoside-binding pocket known confer <br />    Neriifolin member cardiac glycoside family                  resistance Ouabain, member cardiac glycoside <br /> compounds widely used treating heart disorders. To               family, inhibited cardiac glycosides including <br /> determine observed effect Neriifolin VFB DA                 Neriifolin fully functional Na+/K+ ATPase [30]. <br /> neurons characteristic cardiac glycosides, tested              We injected Ouabain-resistant form atp1a3 (hsp70-ATP1A3 <br /> effect cardiac glycoside, Digitoxin (Fig. 1B). When                OR) control construct (hsp-GFP) one-cell stage wild-type <br /> embryos treated Digitoxin 10 mM, number                   zebrafish embryos, performed 90-minute heat shock from <br /> VFB DA neurons decreased (Fig. 1D), suggesting                  22.5 hpf 24 hpf. The heat-shocked embryos subsequently <br /> cardiac glycosides class drugs similar effects disrupting        treated Neriifolin 24 hours (from 48 hpf 72 hpf). RT- <br /> the patterns VFB DA neurons.                                               PCR analysis confirmed expression human atp1a3 the <br />                                                                               experimental control embryos (Fig. 2C). In the <br /> Neriifolin impairs survival, differentiation                   embryos injected hsp70-ATP1A3 OR, Neriifolin-induced DA <br /> VFB DA neurons                                                                neuronal death largely abrogated: VFB DA <br />     To discern Neriifolin impairs specification/                  neurons healthy, DA neurons control embryos <br /> differentiation survival DA neurons, treated embryos             (injected Hsp70-GFP heat shocked) remained defective <br /> at earlier stages, 24 hpf 48 hpf, 4 different                    signs cell shrinkage, membrane fragmentation or <br /> concentrations drug: 1, 5, 10 20 mM. None                 disintegration (Fig. 2D&#226;&#8364;&#8220;E). This data suggest Neriifolin <br /> treatments caused obvious defect pattern VFB DA                 impairs VFB DA neuronal survival interfering Na+/K+ <br /> neurons (Fig. 1E). In contrast, embryos treated                 ATPase activity. <br /> longer time (from 24&#226;&#8364;&#8220;72 hpf), displayed dose-dependent <br /> deficit VFB DA neurons (Fig. 1F 1G). This                  Modulating K+/Na+ ionic homeostasis neuroprotective <br /> simply prolonged drug treatment, embryos treated                 Neriifolin-induced DA neuronal death <br /> from 48&#226;&#8364;&#8220;72 hpf suffered similar deficit DA neurons                    To understand contribution K+ Na+ Neriifolin- <br /> (Fig. 1H): TH staining cytoplasmic control appeared             induced DA neuronal death, modulated concentrations in <br /> fill entire cell Neriifolin-treated embryos, indicating lost       embryonic medium increasing [K+] and/or decreasing <br /> integrity nuclear membrane. These data suggest                    [Na+]. Treatment Neriifolin presence high K+ <br />  <br />  <br />  <br />        PLoS ONE | www.plosone.org                                         2                             April 2012 | Volume 7 | Issue 4 | e35645 <br />                                   Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />  <br />  <br /> PLoS ONE | www.plosone.org   3    April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                          Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />  <br /> Figure 1. Zebrafish chemical screen identifies Neriifolin, member cardiac glycoside family, disrupts pattern DA <br /> neurons ventral forebrain. (A) Schematic diagram chemical screening platform, Neriifolin identified hit that <br /> decreases ventral forebrain DA neurons. (B) Structure cardiac glycosides, Neriifolin Digitoxin, disrupt pattern VFB DA <br /> neurons. (C) Embryos treated 10 mM Neriifolin showed decrease VFB DA neurons (middle panels), Sym NA neurons normal <br /> (right panels). (D) Treatment cardiac glycoside, Digitoxin, similarly decreased VFB DA neurons Sym NA neurons. (E) Embryos <br /> treated different concentrations Neriifolin 24 hpf 48 hpf showed obvious defect pattern VFB DA neurons. (F) Embryos <br /> treated different concentrations Neriifolin 24 hpf 72 hpf displayed impaired DA neuron pattern VFB. The dose response curve is <br /> shown (G). (H) Embryos treated Neriifolin 48&#226;&#8364;&#8220;72 hpf showed deficit VFB DA neurons: neuronal numbers control vs. treated <br /> embryo 64 39 respectively. The insets enlarged views DA neurons, reveal presence TH nucleus, indicating loss of <br /> nuclear membrane integrity. OB, olfactory bulb; VFB, ventral forebrain; sym NA, sympathetic NA neurons; AAC NA, arch-associated NA; LC, locus <br /> coeruleus. <br /> doi:10.1371/journal.pone.0035645.g001 <br />  <br /> (25 mM compared 0 mM control) medium                          significant differences observed (DMSO) &#226;&#8364;&#8220; (Ner- <br /> significantly protected DA neuronal loss compared              iifolin) groups (p = 0.01) (Neriifolin) &#226;&#8364;&#8220; (Neriifolin low Na+) <br /> treatment Neriifolin (Fig. 3A, p = 0.005). However,                groups (p = 0.022), difference (Neriifolin <br /> Neriifolin-induced DA neuronal death partially rescued,              low-Na+) &#226;&#8364;&#8220; (DMSO) groups (p = 0.475) (Fig. 3B). These results <br /> as significant difference remained DMSO group                   suggest Neriifolin-induced DA neuronal death larger <br /> and Neriifolin/high K+ group (Fig. 3A, p,0.001).                          extent caused accumulation Na+ the <br />    Interestingly, embryos treated Neriifolin            depletion K+. Thus, low sodium/high potassium exerts a <br /> low Na+ medium (0.5 mM compared 14.2 mM control),                    neuroprotective effect. <br /> the <span id='am-82' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-83' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-84' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-85' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-86' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-87' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-88' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-89' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-90' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-91' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-92' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-93' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-94' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-95' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-96' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-97' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-98' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-99' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-100' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-101' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-102' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-103' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-104' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-105' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-106' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-107' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-108' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-109' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-110' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-111' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-112' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-113' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-114' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-115' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-116' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-117' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-118' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-119' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-120' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-121' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-122' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-123' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-124' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-125' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-126' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-127' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-128' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-129' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-130' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-131' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-132' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-133' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-134' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-135' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-136' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-137' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-138' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-139' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-140' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-141' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-142' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-143' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-144' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-145' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-146' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-147' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-148' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-149' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-150' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-151' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-152' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-153' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-154' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-155' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-156' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-157' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-158' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-159' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span>phenotype</span> caused Neriifolin completely rescued: <br />  <br />  <br />  <br />  <br /> Figure 2. Human atp1a3 rescues DA neurons Neriifolin-treated embryos. (A) The expression pattern atp1a3a wild-type embryos at <br /> 48 hpf. (B) The schematic diagram plasmid constructs used rescue experiments zebrafish embryos. (C) RT-PCR detection the <br /> expression human atp1a3 zebrafish embryos injection heat shock. (D&#226;&#8364;&#8220;E) Quantification (D) representative images (E) VFB DA <br /> neurons 5 mM Neriifolin-treated embryos express GFP human atp1a3. Data averages 6 SEM 9 embryos single <br /> experiment repeated twice similar results. <br /> doi:10.1371/journal.pone.0035645.g002 <br />  <br />  <br />        PLoS ONE | www.plosone.org                                         4                              April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                          Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />  <br />  <br /> Figure 3. Mechanisms protective strategies Neriifolin-induced DA neuronal death. (A) Treatment Neriifolin presence <br /> of high K+ medium significantly decreased DA neuronal loss compared treatment Neriifolin alone. Data averages 6 SEM <br /> from 6 embryos single experiment repeated twice similar results. (B) Treatment Neriifolin presence low Na+ the <br /> medium significantly decreased DA neuronal loss compared treatment Neriifolin alone. Data averages 6 SEM 8 embryos a <br /> single experiment repeated twice similar results. (C&#226;&#8364;&#8220;D) Treatment Quercetin (C) Ascorbic Acid (D) significantly decreased <br /> DA neuronal death compared treatment Neriifolin alone. Data averages 6 SEM 8 embryos single experiment was <br /> repeated twice similar results. <br /> doi:10.1371/journal.pone.0035645.g003 <br />  <br />  <br /> Two small molecule antioxidants, Quercetin Ascorbic                       Inhibition p53 neuroprotective Neriifolin- <br /> Acid, neuroprotective Neriifolin-induced DA                       induced DA neuronal death <br /> neuronal death                                                                   To gain molecular insight Neriifolin-induced DA neuronal <br />    To understand Neriifolin-induced DA neuronal death                 death, investigated process dependent p53, a <br /> and identify small molecule compounds neuropro-                   tumor suppressor integrates cellular stress signal activates <br /> tective, tested natural food-derived compounds: Quer-                  apoptosis [33&#226;&#8364;&#8220;35]. We determined Neriifolin- <br /> cetin (a flavonoid abundantly present fruits vegetables)               induced DA neuronal death apoptotic performing TUNEL <br /> and Ascorbic Acid (Vitamin C). Both compounds                            labeling. This analysis showed DA neurons are <br /> antioxidant properties exert neuroprotective effect             preferentially TUNEL+ treatment Neriifolin (Fig. 4A&#226;&#8364;&#8220; <br /> oxidative stress-induced neurodegeneration [31,32]. Neriifolin-               B). However, TUNEL staining solely restricted DA <br /> induced DA neuronal death significantly alleviated                 neurons. Nevertheless, TH-positive sympathetic NA neurons, <br /> treatment compound: significant differences                  unaffected Neriifolin, TUNEL2, suggesting <br /> observed Neriifolin control Neriifolin/Querce-                neurons equally affected drug (Fig. 4C&#226;&#8364;&#8220; <br /> tin (Fig. 3C, p,0.01) Neriifolin/Ascorbic Acid groups                      D). Next, injected well-established morpholino antisense <br /> (Fig. 3D, p,0.05). These results suggest Neriifolin-induced              oligonucleotide targeting p53 [36] (with 150 publications in <br /> DA neuronal death large aggravated oxidative                pubMED employing morpholino oligonucleotide) into <br /> stress, caused ionic imbalance ATP1A3                  one-cell stage wild-type embryos (thereof referred p53 <br /> inhibition.                                                                   morphants). Control p53 morphants treated with <br />  <br />  <br />  <br />  <br />        PLoS ONE | www.plosone.org                                         5                              April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                        Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />  <br />  <br /> Figure 4. Neriifolin-induced DA neuronal death apoptotic requires p53. (A&#226;&#8364;&#8220;D90) Low (A&#226;&#8364;&#8220;D) high (A9&#226;&#8364;&#8220;D90) magnification views of <br /> VFB DA neurons control (A-A90) vs Neriifolin-treated embryos (B-B90), sympathetic (Sym) NA neurons control (C-C90) vs Neriifolin-treated <br /> embryos (D-D90). Ventral views 60 hpf embryos shown. Neriifolin treatment carried 24 hpf 60 hpf. (E) Injection p53-MO <br /> into embryos one-cell stage protected DA neurons cell death induced Neriifolin. Data averages 6 SEM 6 embryos single <br /> experiment repeated twice similar results. <br /> doi:10.1371/journal.pone.0035645.g004 <br />  <br />        PLoS ONE | www.plosone.org                                        6                              April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                      Chemical Genetics Dopaminergic Neurons <br />  <br />  <br /> Neriifolin 24 hpf 72 hpf. Impairment p53 activity                affected Neriifolin, given broad Na+/K+ ATPase activity <br /> exerted complete protection DA neurons (Fig. 4E):                detected brain. Although broad expression Na+/K+ <br /> significant difference existed DMSO control                 ATPase neurons including DA neurons favors notion that <br /> Neriifolin group (p = 0.009), difference               DA neuronal death cell autonomous mechanism, also <br /> DMSO control group Neriifolin/p53 morphant group                        makes difficult rule non-cell autonomous contributions <br /> (p = 0.417). This result indicates Neriifolin-induced DA               Neriifolin-induced DA neuronal death. <br /> neuronal apoptosis requires p53.                                               In humans, cardiac glycosides known cross both <br />                                                                             blood-brain barriers placental barriers. Their adverse effects <br /> Impairment DA neuronal survival Neriifolin                         central nervous reported includes <br /> evolutionarily conserved                                                    depression psychosis PD [48,49]. This to <br />    To determine mammalian DA neurons                       fact DA neuron degeneration takes time manifest and <br /> vulnerable Neriifolin, tested effect drug               likely result symptoms later time point the <br /> neurons derived mouse embryonic stem cells (mESCs). The                offensive drug exposure. While known drug <br /> mESC line E14 induced differentiate neurons using           concentrations experienced embryonic larval zebrafish are <br /> monolayer differentiation method [37] (Fig. 5A). After plating              comparable brain drug concentrations human patients, is <br /> mESC cells N2B27 media withdrawal LIF Day 7,                   worth pointing single acute exposure zebrafish to <br /> Nestin+ Sox2+ neural progenitors began emerge                 cardiac glycosides sufficient impair DA neuronal survival. <br /> culture (Fig. S1). On Day 11, progenitors differentiated         Human patients usually drugs longer periods time, <br /> nascent neurons (positive pan-neuronal marker NeuN             lower dose, prolonged exposure cardiac <br /> a subset TH+). On Day 15, NeuN+ TH+ neurons                glycosides affect DA neuronal homeostasis. Interestingly, the <br /> more elaborated processes detected culture, indicative          atp1a3 gene humans previously associated the <br /> of differentiated status. Double labeling midbrain DA             rapid-onset dystonia-parkinsonism (RDP), characterized <br /> neuronal markers TH showed TH+ neurons                   rapid development dystonic spasms, dysarthria, <br /> DA neurons midbrain characteristics (Fig. S2).                       dysphagia, parkinsonism [30]. However, presently not <br />    We treated cells Neriifolin Day 7 11                 known brain DA neurons degenerate particular <br /> (containing neural progenitors nascent neurons)             form parkinsonism. <br /> or Day 11 14 (containing differentiated neurons).               Our study demonstrated importance zebrafish <br /> The quantification carried using InCell 2000                    chemical screening discovering previously unknown toxicity <br /> automated imaging analysis software (Fig. S3). In agreement             therapeutic compounds devising strategies to <br /> with vivo zebrafish data, cells treated Day 11 14       counteract toxicity. Further chemical genetic studies DA <br /> showed decreased TH+ neurons compared vehicle controls                   neuron development survival, including characterizing other <br /> (Fig. 5B&#226;&#8364;&#8220;C), suggesting Neriifolin impairs survival         leads identified screen, identifying chemicals, <br /> than differentiation mammalian DA neurons. Moreover,             employing wild-type, transgenic pharmaco- <br /> decrease TH+ neurons highly significant (p,0.005,                    logical models pre-existing DA neuron degeneration, promise <br /> compared DMSO control) total number neurons                   shed new light etiology PD development of <br /> was significantly affected compared DMSO control                     neuroprotective therapeutics. <br /> (Fig. 5D), suggesting increased sensitivity DA neurons <br /> to Neriifolin.                                                              Materials Methods <br />                                                                             Ethics statement <br /> Discussion                                                                    All work followed NIH guidelines approved the <br />    By screening chemical modulators DA neuron develop-               University California San Francisco Committee Animal <br /> ment survival, uncovered previously unknown                    Research. <br /> vulnerability DA neurons cardiac glycosides also <br /> identified strategies protect DA neurons                   Chemical screening libraries <br /> neurotoxicity class medications. Based data,              To screen small molecules affect differentiation <br /> propose following model (Fig. 6) explain Neriifolin-induced          maintenance DA neurons zebrafish, wild-type embryos <br /> DA neuronal death: Inhibition Na+/K+ ATPase activity                  (in AB genetic background) collected raised Blue <br /> cardiac glycosides causes ionic imbalance; particular,                Egg Water (BEW, 0.12 g. CaSO4, 0.2 g. Instant Ocean, <br /> increased intracellular Na+ levels aggravate oxidative stress.              30 microliters methylene blue 1 L water) 24 hpf. After <br /> Through unknown mechanism, oxidative stress activates            removal chorions, embryos transferred 96-well-deep- <br /> p53, subsequently unleashes apoptotic cell death                  polypropylene plates (Fisher, #12-566-120, n = 3 embryos <br /> pathway. Since DA neurons known highly susceptible                well) containing 10 mM chemicals (in 400 ml total volume). <br /> to oxidative stress intrinsic metabolic processes [38],         DMSO concentration 1%. Embryos treated with <br /> may explain increased vulnerability DA neurons                    chemicals 24&#226;&#8364;&#8220;72 hours 28uC. At end chemical <br /> Neriifolin, neurotoxic compounds                treatment, embryos observed dissecting microscope <br /> MPTP [39&#226;&#8364;&#8220;43] rotenone [43,44], selectively (in            abnormal morphologies recorded, including heart <br /> case MPTP) non-selectively (in case rotenone) enter            rate, cardiac edema, overall body shape. Afterwards, embryos <br /> DA neurons inhibit activity mitochondrial complex I           transferred mesh-bottom-96-PCR plate immuno- <br /> the electron transport chain [45&#226;&#8364;&#8220;47].                                       staining polyclonal TH antibody (custom-made, 1:1000), <br />    While data sympathetic NA neurons                  followed visualization DA NA neurons a <br /> unaffected Neriifolin zebrafish overall neuronal              fluorescent dissecting microscope (Leica). <br /> numbers significantly reduced Neriifolin-treated mESC               Chemical libraries provided UCSF Small Molecule <br /> cultures, unlikely DA neurons neuronal type         Discovery Center (SMDC). Two libraries screened: Micro- <br />  <br />  <br />       PLoS ONE | www.plosone.org                                        7                             April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                          Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />  <br />  <br /> Figure 5. Neriifolin selectively impairs survival mammalian DA neurons derived embryonic stem cells (ESCs). (A) <br /> Schematic diagram protocol used induce DA neuron differentiation mouse ESCs. (B) Representative views wells different <br /> treatment, showing percentage TH+ neurons (TH, marker DA neurons, red) neurons (NeuN, neuronal marker, green) among <br /> total cells (DAPI). Compared DMSO control (upper panel), cells treated Neriifolin Day 7 11 (middle panels) showed decrease <br /> in percentage TH+ neurons neurons; cells treated Neriifolin day 11 14 (lower panels) showed significant less <br /> percentage DA neurons. (C) Quantification percentage TH+ neurons total cells. Fold change treatment vs DMSO control was <br /> shown. (D) Quantification fold change TH+ neurons neurons. In (C) (D), data averages 6 SEM triplicates single <br /> experiment repeated 3 times similar results. <br /> doi:10.1371/journal.pone.0035645.g005 <br />  <br />  <br />        PLoS ONE | www.plosone.org                                         8                              April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                         Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />                                                                               mRNA [36]. The standard control morpholino Gene Tools <br />                                                                               INc. used. Control p53 morpholinos injected into <br />                                                                               one-cell-stage embryos, raised Blue Egg Water until <br />                                                                               24 hours, transferred Embryo Medium 24-well-plate <br />                                                                               treated 5 mM Neriifolin. At 72 hpf, embryos were <br />                                                                               collected fixed, stained anti-TH antibody. <br />  <br />                                                                               Mouse ESC culture DA neuronal differentiation <br />                                                                                  Mouse embryonic stem cell line E14Tg2a used [53]. E14 <br />                                                                               cells cultured GMEM media (Sigma, G5154) supplement- <br />                                                                               ed glutamine, sodium pyruvate, 0.1 mM MEM non-essential <br />                                                                               amino acids, 10% (v/v) fetal bovine serum (characterized, <br />                                                                               Hyclone), beta-mercaptoethanol, 500&#226;&#8364;&#8220;1000 units ml of <br />                                                                               leukocyte inhibitory factor (Chemicon ESG1107), gelatinized <br />                                                                               cell culture surface feeder cells. <br />                                                                                  To induce neuronal differentiation, monolayer differentia- <br />                                                                               tion protocol developed Ying et al used [54]. Briefly, on <br />                                                                               Day 1, E14 cells dissociated Trypsin-EDTA (TE) into <br />                                                                               single cells plated gelatinized cell culture dish density <br /> Figure 6. A schematic model showing effect cardiac <br /> glycosides DA neuronal death. We propose inhibition                1.06104 cell/cm2 N2B27 media. Cells cultured in <br /> Na+/K+ ATPase activity leads increased intracellular sodium,         N2B27 media 7 days (with media changes day) to <br /> triggers production reactive oxygen species (ROS) activation       differentiate ESCs neural progenitors. On day 7, cells were <br /> of p53-mediated apoptotic cell death pathway. Future biochemical              dissociated TE re-plated poly-L-ornithine-laminin <br /> experiments needed test model.                            coated 96-well plates N2B27 media. Media changed every <br /> doi:10.1371/journal.pone.0035645.g006 <br />                                                                               2 days re-plating. On Day 15, cells fixed PFA and <br />                                                                               immunostained antibody analysis differentiation of <br /> source Celera_IFLabs. The Microsource library contains                    TH neurons neurons. For chemical treatment, chemical was <br /> 1520 compounds Celera library contains 3500 com-                      diluted media Day 8 Day 11 treatment lasted 4 <br /> pounds.                                                                       days, media changes day. <br />                                                                                  Primary antibody immunocytochemistry included: Rabbit- <br /> Immunostaining confocal microscopy                                        anti-TH, 1:2000 (Millipore, AB152); Mouse-anti-NeuN, 1:600 <br />    TH immunostaining carried previously described                  (Millipore, MAB377); Nurr1 (Santa Cruz, Sc-991), Lmx1a (a <br /> [50,51]. TUNEL labeling performed according                        generous gift Dr. M. S. German, UCSF). After immuno- <br /> manufacturer&#226;&#8364;&#8482;s protocol (Roche In situ Cell Death Detection                   staining, images taken using automated imaging system <br /> Kit). Immunostained zebrafish embryos mounted glycerol                InCell 2000 (GE). 20 views images taken and <br /> and imaged using Leica SP2 confocal microscope stack                view, images 3 channels taken (TH, NeuN plus <br /> roughly 100 optical sections taken approximately 1 mm apart                DAPI). Image stacks segmented quantified using the <br /> the z-dimension. This stack images imported ImageJ                software InCell developer. The percentage TH neurons all <br /> software average intensity projections created              neurons calculated accordingly. <br /> zebrafish embryo. <br />                                                                               Supporting Information <br /> In situ hybridization                                                         Figure S1 Characterization neuronal progenitors in <br />   In situ hybridization carried previously described               Day 7 mESC culture. At stage, cells culture were <br /> [50].                                                                         neuronal progenitors, evidenced expression Sox2 (top) <br />                                                                               Nestin (bottom). <br /> Plasmids, morpholinos, microinjection                                     (TIF) <br />    The hsp70 promoter [52] used drive human ATP1A3 <br /> WT OR cDNA (a generous gift Dr. L. Ozelius). The plasmid                 Figure S2 Many TH+ cells mESC culture of <br /> DNA micro-injected one-cell stage wild-type embryos             midbrain DA identity. Top panels: midbrain DA markers <br /> concentration 40 ng/ml, 10 ng/ml transposase                 Nurr1; middle panels: midbrain DA markers Lmx1a; bottome <br /> RNA increase integration DNA decrease possible mosaic               panels: pan neuronal marker NeuN. <br /> expression. At 22.5 hpf, embryos normal morphology                  (TIF) <br /> heat-shocked 37uC 90 minutes. 24 hours heat shock                Figure S3 Quantification using automated INCell im- <br /> (around 48 hpf), de-chorioned embryos transferred                   aging analysis software. Representative images showing the <br /> freshly embryo media (NaCl, 13.7 mM; KCl, 0.5 mM;                        segmentation method used InCell Developer software (A). (B) <br /> Na2HPO4, 25 mM; KH2PO4, 44 mM; CaCl2, 1.3 mM; MgSO4,                          Targets different channels segmented separately and <br /> 1 mM; NaHCO3, 0.41 mM; pH 7.2), 5 mM Neriifolin                          area targets views summarized. <br /> (DMSO final concentration 0.5%). Neriifolin treatment lasted                  TH% total cells calculated based areas from <br /> from 48 hpf 80 hpf. The embryos collected                         TH channel DNA channels (Cal TH). The fold change <br /> immunostained afterwards.                                                     certain treatment (e.g. Neriifolin) calculated by <br />    The sequence p53 morpholino is: GCGCC-                             computing ratio control (e.g. DMSO). <br /> ATTGCTTTGCAAGAATTG, targets ATG p53                              (TIF) <br />  <br />  <br />  <br />        PLoS ONE | www.plosone.org                                         9                              April 2012 | Volume 7 | Issue 4 | e35645 <br />                                                                                                                               Chemical Genetics Dopaminergic Neurons <br />  <br />  <br />  <br /> Acknowledgments                                                                                Author Contributions <br /> We thank Drs. Michelle Arkin Kean-hooi Ang UCSF Small                               Conceived designed experiments: YS ZD HK SG. Performed the <br /> Molecule Discovery Center (SMDC) aspects technical                                 experiments: YS ZD HK SC. Analyzed data: YS ZD HK SC SG. <br /> assistance screening, Drs. Michael Keiser Brian                             Wrote paper: YS SG. <br /> Shoichet valuable advice chemi-informatics, Dr. L. Ozelius for <br /> the human ATP1A3 WT OR cDNA, Guo lab members helpful <br /> discussions. <br />  <br /> References <br /> 1.    Bjo&#194;&#168;rklund A, Lindvall O (1984) Dopamine-containing systems CNS. In:              24. Rihel J, Prober DA, Arvanites A, Lam K, Zimmerman S, et al. (2010) Zebrafish <br />       Bjo&#194;&#168; rklund A, Ho&#194;&#168; kfelt T, eds. Handbook Chemical Neuroanatomy.                          behavioral profiling links drugs biological targets rest/wake regulation. <br />       Amsterdam: Elsevier. pp 55&#226;&#8364;&#8220;122.                                                              Science 327: 348&#226;&#8364;&#8220;351. <br /> 2.    Goldstein DS, Eisenhofer G, McCarty R (1998) Catecholamines: bridging basic              25. Kokel D, Bryan J, Laggner C, White R, Cheung CY, et al. (2010) Rapid <br />       science clinical medicine; August JT, Anders MW, Murad F, Coyle JT, eds.                behavior-based identification neuroactive small molecules zebrafish. <br />       San Diego, California: Academic Press.                                                       Nat Chem Biol 6: 231&#226;&#8364;&#8220;237. <br /> 3.    Chaudhuri KR, Schapira AH (2009) Non-motor symptoms Parkinson&#226;&#8364;&#8482;s                       26. Prassas I, Diamandis EP (2008) Novel therapeutic applications cardiac <br />       disease: dopaminergic pathophysiology treatment. Lancet Neurol 8:                        glycosides. Nat Rev Drug Discov 7: 926&#226;&#8364;&#8220;935. <br />       464&#226;&#8364;&#8220;474.                                                                                 27. McGrail KM, Phillips JM, Sweadner KJ (1991) Immunofluorescent localization <br /> 4.    Meissner WG, Frasier M, Gasser T, Goetz CG, Lozano A, et al. (2011) Priorities               Na,K-ATPase isozymes rat central nervous system: neurons <br />       Parkinson&#226;&#8364;&#8482;s disease research. Nat Rev Drug Discov 10: 377&#226;&#8364;&#8220;393.                            glia express Na,K-ATPase. J Neurosci 11: 381&#226;&#8364;&#8220;391. <br /> 5.    Smeets WJAJ, Reiner A (1994) Phylogeny development catecholamine                  28. Rajarao SJ, Canfield VA, Mohideen MA, Yan YL, Postlethwait JH, et al. (2001) <br />       systems CNS vertebrates. Cambridge, England: Cambridge University                  The repertoire Na,K-ATPase alpha beta subunit genes expressed the <br />       Press.                                                                                       zebrafish, Danio rerio. Genome Res 11: 1211&#226;&#8364;&#8220;1220. <br /> 6.    Guo S, Wilson SW, Cooke S, Chitnis AB, Driever W, et al. (1999) Mutations             29. Thisse C, Thisse B (2005) High Throughput Expression Analysis ZF-Models <br />       zebrafish unmask shared regulatory pathways controlling development               Consortium Clones. ZFIN Direct Data Submission (ZFIN web site, available <br />       catecholaminergic neurons. Dev Biol 208: 473&#226;&#8364;&#8220;487.                                            http://zfin.org. Accessed March 26 2012). <br /> 7.    Holzschuh J, Ryu S, Aberger F, Driever W (2001) Dopamine transporter                     30. Carvalho Aguiar P, Sweadner KJ, Penniston JT, Zaremba J, Liu L, et al. <br />       expression distinguishes dopaminergic neurons catecholaminergic                   (2004) Mutations Na+/K+ -ATPase alpha3 gene ATP1A3 associated <br />       neurons developing zebrafish embryo. Mech Dev 101: 237&#226;&#8364;&#8220;243.                           rapid-onset dystonia parkinsonism. Neuron 43: 169&#226;&#8364;&#8220;175. <br /> 8.    Ma PM (2003) Catecholaminergic systems zebrafish IV. Organization             31. Heo HJ, Lee CY (2004) Protective effects quercetin vitamin C against <br />       projection pattern dopaminergic neurons diencephalon. J Comp Neurol                oxidative stress-induced neurodegeneration. J Agric Food Chem 52: 7514&#226;&#8364;&#8220;7517. <br />       460: 13&#226;&#8364;&#8220;37.                                                                              32. Bournival J, Quessy P, Martinoli MG (2009) Protective effects resveratrol and <br /> 9.    McLean DL, Fetcho JR (2004) Ontogeny innervation patterns                             quercetin MPP+ -induced oxidative stress act modulating markers of <br />       dopaminergic, noradrenergic, serotonergic neurons larval zebrafish.                   apoptotic death dopaminergic neurons. Cell Mol Neurobiol 29: 169&#226;&#8364;&#8220;180. <br />       J Comp Neurol 480: 38&#226;&#8364;&#8220;56.                                                                33. Giaccia AJ, Kastan MB (1998) The complexity p53 modulation: emerging <br /> 10.   Tay TL, Ronneberger O, Ryu S, Nitschke R, Driever W (2011) Comprehensive                     patterns divergent signals. Genes Dev 12: 2973&#226;&#8364;&#8220;2983. <br />       catecholaminergic projectome analysis reveals single-neuron integration               34. Fridman JS, Lowe SW (2003) Control apoptosis p53. Oncogene 22: <br />       zebrafish ascending descending dopaminergic systems. Nat Commun 2:                       9030&#226;&#8364;&#8220;9040. <br />       171.                                                                                     35. Haupt S, Berger M, Goldberg Z, Haupt Y (2003) Apoptosis - p53 network. <br /> 11.   Rink E, Wullimann MF (2001) The teleostean (zebrafish) dopaminergic                   J Cell Sci 116: 4077&#226;&#8364;&#8220;4085. <br />       ascending subpallium (striatum) located basal diencephalon              36. Langheinrich U, Hennen E, Stott G, Vacun G (2002) Zebrafish model <br />       (posterior tuberculum). Brain Res 889: 316&#226;&#8364;&#8220;330.                                              organism identification characterization drugs genes affecting <br /> 12.   Rink E, Wullimann MF (2002) Connections ventral telencephalon                     p53 signaling. Curr Biol 12: 2023&#226;&#8364;&#8220;2028. <br />       tyrosine hydroxylase distribution zebrafish brain (Danio rerio) lead           37. Ying QL, Stavridis M, Griffiths D, Li M, Smith A (2003) Conversion of <br />       identification ascending dopaminergic teleost. Brain Res Bull              embryonic stem cells neuroectodermal precursors adherent monoculture. <br />       57: 385&#226;&#8364;&#8220;387.                                                                                 Nat Biotechnol 21: 183&#226;&#8364;&#8220;186. <br /> 13.   Zon LI, Peterson RT (2005) In vivo drug discovery zebrafish. Nat Rev Drug             38. Miyazaki I, Asanuma M (2008) Dopaminergic neuron-specific oxidative stress <br />       Discovery 4: 35&#226;&#8364;&#8220;44.                                                                          caused dopamine itself. Acta Med Okayama 62: 141&#226;&#8364;&#8220;150. <br /> 14.   Guo S (2009) Using zebrafish assess impact drugs neural                     39. Chiueh CC, Markey SP, Burns R, Johannessen JN, Jacobowitz DM, et al. (1984) <br />       development function. Expert Opin Drug Discov 4: 715&#226;&#8364;&#8220;726.                                Neurochemical behavioral effect MPTP rat, quinea pig monkey. <br /> 15.   Yu PB, Hong CC, Sachidanandan C, Babitt JL, Deng DY, et al. (2008)                           Psychopharmacol Bull 20: 546&#226;&#8364;&#8220;553. <br />       Dorsomorphin inhibits BMP signals required embryogenesis iron                    40. Lam CS, Korzh V, Strahle U (2005) Zebrafish embryos susceptible the <br />       metabolism. Nat Chem Biol 4: 33&#226;&#8364;&#8220;41.                                                          dopaminergic neurotoxin MPTP. Eur J Neurosci 21: 1758&#226;&#8364;&#8220;1762. <br /> 16.   Molina G, Vogt A, Bakan A, Dai W, Queiroz Oliveira P, et al. (2009)                   41. McKinley ET, Baranowski TC, Blavo DO, Cato C, Doan TN, et al. (2005) <br />       Zebrafish chemical screening reveals inhibitor Dusp6 expands cardiac              Neuroprotection MPTP-induced toxicity zebrafish dopaminergic neurons. <br />       cell lineages. Nat Chem Biol 5: 680&#226;&#8364;&#8220;687.                                                     Brain Res Mol Brain Res 141: 128&#226;&#8364;&#8220;137. <br /> 17.   Stern HM, Murphey RD, Shepard JL, Amatruda JF, Straub CT, et al. (2005)                  42. Sallinen V, Torkko V, Sundvik M, Reenila&#194;&#168; I, Khrustalyov D, et al. (2009) MPTP <br />       Small molecules delay S phase suppress zebrafish bmyb mutant. Nat                     MPP+ target specific aminergic cell populations larval zebrafish. <br />       Chem Biol 1: 366&#226;&#8364;&#8220;370.                                                                        J Neurochem 108: 719&#226;&#8364;&#8220;731. <br /> 18.   North TE, Goessling W, Walkley CR, Lengerke C, Kopani KR, et al. (2007)                  43. Bretaud S, Lee S, Guo S (2004) Sensitivity zebrafish environmental toxins <br />       Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis.                  implicated Parkinson&#226;&#8364;&#8482;s disease. Neurotox Teratol 26: 857&#226;&#8364;&#8220;864. <br />       Nature 447: 1007&#226;&#8364;&#8220;1011.                                                                   44. Betarbet R, Sherer TB, MacKenzie G, Garcia-Osuna M, Panov AV, et al. <br /> 19.   Yeh JR, Munson KM, Elagib KE, Goldfarb AN, Sweetser DA, et al. (2009)                        (2000) Chronic systemic pesticide exposure reproduces features Parkinson&#226;&#8364;&#8482;s <br />       Discovering chemical modifiers oncogene-regulated hematopoietic differen-                 disease. Nat Neurosci 3: 1301&#226;&#8364;&#8220;1306. <br />       tiation. Nat Chem Biol 5: 236&#226;&#8364;&#8220;243.                                                       45. Greenamyre JT, Betarbet R, Sherer TB (2003) The rotenone model of <br /> 20.   Hicken CE, Linbo TL, Baldwin DH, Willis ML, Myers MS, et al. (2011)                          Parkinson&#226;&#8364;&#8482;s disease: genes, environment mitochondria. Parkinsonism and <br />       Sublethal exposure crude oil embryonic development alters cardiac                  related disorders 9: S59&#226;&#8364;&#8220;S64. <br />       morphology reduces aerobic capacity adult fish. Proc Natl Acad Sci U S A          46. Perier C, Bove J, Vila M, Przedborski S (2003) The rotenone model of <br />       108: 7086&#226;&#8364;&#8220;7090.                                                                              Parkinson&#226;&#8364;&#8482;s disease. Trends Neurosci 26: 345&#226;&#8364;&#8220;346. <br /> 21.   North TE, Babu IR, Vedder LM, Lord AM, Wishnok JS, et al. (2010) PGE2-                   47. Speciale SG (2002) MPTP: insights parkinsonian degeneration. Neurotox- <br />       regulated wnt signaling N-acetylcysteine synergistically hepatoprotective            icol Teratol. pp 607&#226;&#8364;&#8220;620. <br />       zebrafish acetaminophen injury. Proc Natl Acad Sci U S A 107:                         48. Song YH, Terao T, Shiraishi Y, Nakamura J (2001) Digitalis intoxication <br />       17315&#226;&#8364;&#8220;17320.                                                                                 misdiagnosed depression&#226;&#8364;&#8220;revisited. Psychosomatics 42: 369&#226;&#8364;&#8220;370. <br /> 22.   Peterson RT, Shaw SY, Peterson TA, Milan DJ, Zhong TP, et al. (2004)                     49. Carney MW, Rapp S, Pearce K (1985) Digoxin toxicity presenting with <br />       Chemical suppression genetic <span id='am-160' about='Thesaurus:TESSE01' typeof='owl:Thing'><span id='am-161' property="rdfs:label" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-162' property="Thesaurus:Preferred_Name" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-163' property="Thesaurus:Preferred_Name" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-164' property="Thesaurus:Preferred_Name" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-165' property="Thesaurus:Preferred_Name" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-166' property="Thesaurus:Preferred_Name" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-167' property="rdfs:label" content="knockout" datatype="rdf:PlainLiteral"></span><span id='am-168' property="Thesaurus:Preferred_Name" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-169' property="Thesaurus:Preferred_Name" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-170' property="Thesaurus:code" content="TEESS18" datatype="rdf:PlainLiteral"></span><span id='am-171' property="Thesaurus:Preferred_Name" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-172' property="Thesaurus:code" content="TEESS11" datatype="rdf:PlainLiteral"></span><span id='am-173' property="rdfs:label" content="Mutation" datatype="rdf:PlainLiteral"></span><span id='am-174' property="rdfs:label" content="Deletion mutation" datatype="rdf:PlainLiteral"></span><span id='am-175' property="rdfs:label" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-176' property="rdfs:label" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-177' property="rdfs:label" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-178' property="Thesaurus:code" content="TEESS20" datatype="rdf:PlainLiteral"></span><span id='am-179' property="Thesaurus:code" content="TEESS10" datatype="rdf:PlainLiteral"></span><span id='am-180' property="Thesaurus:Preferred_Name" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-181' property="Thesaurus:code" content="TEESS03" datatype="rdf:PlainLiteral"></span><span id='am-182' property="Thesaurus:code" content="TEESS23" datatype="rdf:PlainLiteral"></span><span id='am-183' property="rdfs:label" content="null allele" datatype="rdf:PlainLiteral"></span><span id='am-184' property="Thesaurus:code" content="TEESS25" datatype="rdf:PlainLiteral"></span><span id='am-185' property="rdfs:label" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-186' property="Thesaurus:code" content="TEESS06" datatype="rdf:PlainLiteral"></span><span id='am-187' property="Thesaurus:code" content="TEESS09" datatype="rdf:PlainLiteral"></span><span id='am-188' property="Thesaurus:Preferred_Name" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-189' property="Thesaurus:code" content="TEESS22" datatype="rdf:PlainLiteral"></span><span id='am-190' property="rdfs:label" content="Gene mutation" datatype="rdf:PlainLiteral"></span><span id='am-191' property="Thesaurus:Preferred_Name" content="Novel mutation" datatype="rdf:PlainLiteral"></span><span id='am-192' property="Thesaurus:Preferred_Name" content="Targeted mutation" datatype="rdf:PlainLiteral"></span><span id='am-193' property="Thesaurus:code" content="TEESS02" datatype="rdf:PlainLiteral"></span><span id='am-194' property="Thesaurus:code" content="TEESS13" datatype="rdf:PlainLiteral"></span><span id='am-195' property="Thesaurus:Preferred_Name" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-196' property="rdfs:label" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-197' property="rdfs:label" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-198' property="rdfs:label" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-199' property="Thesaurus:Preferred_Name" content="Frameshift mutation" datatype="rdf:PlainLiteral"></span><span id='am-200' property="Thesaurus:code" content="TEESS21" datatype="rdf:PlainLiteral"></span><span id='am-201' property="Thesaurus:Preferred_Name" content="Insertion mutation" datatype="rdf:PlainLiteral"></span><span id='am-202' property="rdfs:label" content="RNA Interference" datatype="rdf:PlainLiteral"></span><span id='am-203' property="rdfs:label" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-204' property="rdfs:label" content="RNA interference pathway" datatype="rdf:PlainLiteral"></span><span id='am-205' property="Thesaurus:Preferred_Name" content="Germline mutation" datatype="rdf:PlainLiteral"></span><span id='am-206' property="Thesaurus:Preferred_Name" content="Deleterious mutation" datatype="rdf:PlainLiteral"></span><span id='am-207' property="rdfs:label" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-208' property="rdfs:label" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-209' property="Thesaurus:code" content="TEESS12" datatype="rdf:PlainLiteral"></span><span id='am-210' property="Thesaurus:Preferred_Name" content="lethal phenotype" datatype="rdf:PlainLiteral"></span><span id='am-211' property="Thesaurus:code" content="TEESS04" datatype="rdf:PlainLiteral"></span><span id='am-212' property="Thesaurus:Preferred_Name" content="cell survival" datatype="rdf:PlainLiteral"></span><span id='am-213' property="Thesaurus:code" content="TEESS01" datatype="rdf:PlainLiteral"></span><span id='am-214' property="Thesaurus:code" content="TEESS24" datatype="rdf:PlainLiteral"></span><span id='am-215' property="Thesaurus:code" content="TEESS17" datatype="rdf:PlainLiteral"></span><span id='am-216' property="Thesaurus:code" content="TEESS14" datatype="rdf:PlainLiteral"></span><span id='am-217' property="Thesaurus:Preferred_Name" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-218' property="Thesaurus:Preferred_Name" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-219' property="Thesaurus:Preferred_Name" content="Missense mutation" datatype="rdf:PlainLiteral"></span><span id='am-220' property="Thesaurus:Preferred_Name" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-221' property="rdfs:label" content="null mutants" datatype="rdf:PlainLiteral"></span><span id='am-222' property="rdfs:label" content="Induced mutation" datatype="rdf:PlainLiteral"></span><span id='am-223' property="rdfs:label" content="Gene knockout" datatype="rdf:PlainLiteral"></span><span id='am-224' property="Thesaurus:code" content="TEESS15" datatype="rdf:PlainLiteral"></span><span id='am-225' property="rdfs:label" content="survival" datatype="rdf:PlainLiteral"></span><span id='am-226' property="rdfs:label" content="Point mutation" datatype="rdf:PlainLiteral"></span><span id='am-227' property="Thesaurus:code" content="TEESS16" datatype="rdf:PlainLiteral"></span><span id='am-228' property="rdfs:label" content="Knock-out" datatype="rdf:PlainLiteral"></span><span id='am-229' property="rdfs:label" content="Mutation analysis" datatype="rdf:PlainLiteral"></span><span id='am-230' property="Thesaurus:code" content="TEESS07" datatype="rdf:PlainLiteral"></span><span id='am-231' property="rdfs:label" content="Silent mutation" datatype="rdf:PlainLiteral"></span><span id='am-232' property="Thesaurus:Preferred_Name" content="Nonsense mutation" datatype="rdf:PlainLiteral"></span><span id='am-233' property="Thesaurus:code" content="TEESS08" datatype="rdf:PlainLiteral"></span><span id='am-234' property="Thesaurus:code" content="TEESS05" datatype="rdf:PlainLiteral"></span><span id='am-235' property="Thesaurus:Preferred_Name" content="phenotype" datatype="rdf:PlainLiteral"></span><span id='am-236' property="Thesaurus:code" content="TEESS19" datatype="rdf:PlainLiteral"></span><span id='am-237' property="Thesaurus:Preferred_Name" content="Gene mutation" datatype="rdf:PlainLiteral"></span>mutation</span> zebrafish model aortic                    psychosis patient chronic phobic anxiety. Clin Neuropharmacol 8: <br />       coarctation. Nat Biotech 22: 595&#226;&#8364;&#8220;599.                                                        193&#226;&#8364;&#8220;195. <br /> 23.   Kawahara G, Karpf JA, Myers JA, Alexander MS, Guyon JR, et al. (2011) Drug               50. Guo S, Brush J, Teraoka H, Goddard A, Wilson SW, et al. (1999) Development <br />       screening zebrafish model Duchenne muscular dystrophy. Proc Natl                     noradrenergic neurons zebrafish hindbrain requires BMP, FGF8, and <br />       Acad Sci U S A 108: 5331&#226;&#8364;&#8220;5336.                                                               homeodomain protein Soulless/Phox2a. Neuron 24: 555&#226;&#8364;&#8220;566. <br />  <br />  <br />  <br />          PLoS <br /> </body></html>